Back to Journals » Biologics: Targets and Therapy

Biologics: Targets and Therapy

ISSN: 1177-5491

ISSN: 1177-5475 (Print) - went to online only in 2009

An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).







Latest articles:

- 5 records -

Stem Cell Therapy for Burns: Story so Far

Abdul Kareem N, Aijaz A, Jeschke MG

Biologics: Targets and Therapy 2021, 15:379-397

Published Date: 31 August 2021

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease

Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG

Biologics: Targets and Therapy 2021, 15:363-374

Published Date: 27 August 2021

Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing

Mengstie MA, Wondimu BZ

Biologics: Targets and Therapy 2021, 15:353-361

Published Date: 21 August 2021

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician

Findeisen KE, Sewell J, Ostor AJK

Biologics: Targets and Therapy 2021, 15:343-352

Published Date: 12 August 2021


Read more articles